The specificity of the interaction between αB-crystallin and desmin filaments and its impact on filament aggregation and cell viability

CRYAB (αB-crystallin) is expressed in many tissues and yet the R120G mutation in CRYAB causes tissue-specific pathologies, namely cardiomyopathy and cataract. Here, we present evidence to demonstrate that there is a specific functional interaction of CRYAB with desmin intermediate filaments that predisposes myocytes to disease caused by the R120G mutation.We use a variety of biochemical and biophysical techniques to show that plant, animal and ascidian small heatshock proteins (sHSPs) can interact with intermediate filaments. Nevertheless, the mutation R120G in CRYAB does specifically change that interaction when compared with equivalent substitutions in HSP27 (R140G) and into the Caenorhabditis elegans HSP16.2 (R95G). By transient transfection, we show that R120G CRYAB specifically promotes intermediate filament aggregation in MCF7 cells. The transient transfection of R120G CRYAB alone has no significant effect upon cell viability, although bundling of the endogenous intermediate filament
network occurs and themitochondria are concentrated into the perinuclear
region. The combination of R120G CRYAB co-transfected with wild-type
desmin, however, causes a significant reduction in cell viability. Therefore, we
suggest that while there is an innate ability of sHSPs to interact with and to
bind to intermediate filaments, it is the specific combination of desmin and
CRYAB that compromises cell viability and this is potentially the key to the
muscle pathology caused by the R120G CRYAB.